High incidence of BCR-ABL kinase domain mutations and absence of mutations of the PDGFR and KIT activation loops in CML patients with secondary resistance to imatinib

Haifa Kathrin Al-Ali, Michael Charles Heinrich, Thoralf Lange, Rainer Krahl, Matthias Mueller, Christel Müller, Dietger Niederwieser, Brian James Druker, Michael Werner Nikolaus Deininger

Research output: Contribution to journal › Article › peer-review

96 Scopus citations

Fingerprint

Dive into the research topics of 'High incidence of BCR-ABL kinase domain mutations and absence of mutations of the PDGFR and KIT activation loops in CML patients with secondary resistance to imatinib'. Together they form a unique fingerprint.

Medicine & Life Sciences